LogicBio Therapeutics (LOGC) Misses Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +82.6%
Financial Fact:
Total operating expenses: 292.2K
Today's EPS Names:
CRMT, PKE, HELE, More
EPS Growth %: +82.6%
Financial Fact:
Total operating expenses: 292.2K
Today's EPS Names:
CRMT, PKE, HELE, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q4 EPS of ($0.08).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
- Nocera files to register 7.5 million shares under SEC Form S-3
- Zhipu AI prices HK offering at HK$1,588/share - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
